Literature DB >> 6690268

Biological activity of bacterial derived human growth hormone in adipose tissue of hypophysectomized rats.

H M Goodman.   

Abstract

Segments of epididymal fat from hypophysectomized rats were incubated in Krebs-Ringer bicarbonate buffer for 1-4 h. Responses to three bacterially synthesized human GH (hGH) preparations were compared with responses to two highly purified pituitary hGH preparations. Hormones of both bacterial and pituitary origin increased the rate of oxidation of [U14C] glucose to 14CO2 and antagonized epinephrine-stimulated lipolysis. These insulin-like effects were produced over a range of 30-300 ng/ml hGH, and their concentration dependence was quite similar regardless of the source of hormone. Exposure of tissues to GH in the first hour of incubation makes them refractory to the insulin-like actions of a test dose of GH added in the fourth hour of incubation. hGH of either pituitary or bacterial origin also appeared to be equipotent in producing such refractoriness. The minimal effective concentration for this response fell between 10 and 30 ng/ml. Hormones from both sources were also capable of displacing 125I-labeled hGH from specific binding sites on isolated adipocytes, and the displacement curves were superimposable. Fifty percent displacement was seen at concentrations in the range of 10-20 ng/ml. Cell preparations produced a delayed increase in lipolysis which was evident in the presence of 0.3 mg/ml of theophylline in the fourth hour of incubation. In this regard, two of the bacterial hGH preparations were more potent than pituitary hGH and produced statistically significant increases in lipolysis at concentrations 10-30 times lower than pituitary hGH studied simultaneously in tissues of the same rats. Despite the presence of less than 1% contamination with bacterial protein, the greater potency of the bacterial hGH may be due to material of bacterial origin, since one bacterial hGH preparation, which was further purified to remove 99% of the remaining bacterial contamination was equipotent with pituitary hGH. These data indicate that a protein hormone synthesized in bacteria, and therefore likely to be free of peptides which might contaminate hGH purified from pituitary extracts, has all of the diverse physiological effects in adipose tissue that have been observed with preparations of GH derived from pituitary glands. These findings lend strong support to the conclusion that both insulin-like and lipolytic actions of GH are intrinsic properties of the molecule and cannot be attributed to contaminants present in the pituitary extract.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690268     DOI: 10.1210/endo-114-1-131

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  A new natural hGH variant--17.5 kd--produced by alternative splicing. An additional consensus sequence which might play a role in branchpoint selection.

Authors:  C M Lecomte; A Renard; J A Martial
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

2.  Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.

Authors:  J L Kostyo; C M Cameron; K C Olson; A J Jones; R C Pai
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  A comparison of the growth-promoting, lipolytic, diabetogenic and immunological properties of pituitary and recombinant-DNA-derived bovine growth hormone (somatotropin).

Authors:  I C Hart; P M Chadwick; T C Boone; K E Langley; C Rudman; L M Souza
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

4.  The effect of human growth hormone therapy on skinfold thickness in growth hormone-deficient children.

Authors:  J M Wit; M A van't Hof; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

5.  The relationship between serum and cell type on the development of rat and pig cultured preadipocytes.

Authors:  D E Jewell; G J Hausman
Journal:  Cytotechnology       Date:  1989-05       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.